Chinese Medical Sciences Journal ›› 2011, Vol. 26 ›› Issue (4): 246-248.doi: 10.1016/S1001-9294(12)60009-1

• Case Report • 上一篇    下一篇

Lack of Response in Severe Pneumocystis Pneumonia to Combined Caspofungin and Clindamycin Treatment: a Case Report

Yao Zhang1, Hua Zhang2, Jun Xu3, Chan Wu4, and Xiao-jun Ma1*   

  1. 1Department of Infectious Diseases, 4 Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China; 2Department of Scientific Researches, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China; 3Department of Medicine, Provincial Infectious Disease Hospital of Uygur Autonomous Region, Urumqi 830013, China
  • 收稿日期:2011-06-13 出版日期:2011-12-30 发布日期:2011-12-30
  • 通讯作者: Corresponding author Tel: 86-10-65296549, Fax: 86-10-65296351, E-mail: drmaxiaojun@gmail.com E-mail:drmaxiaojun@gmail.com

Lack of Response in Severe Pneumocystis Pneumonia to Combined Caspofungin and Clindamycin Treatment: a Case Report

Yao Zhang1, Hua Zhang2, Jun Xu3, Chan Wu4, and Xiao-jun Ma1*   

  1. 1Department of Infectious Diseases, 4 Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China; 2Department of Scientific Researches, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China; 3Department of Medicine, Provincial Infectious Disease Hospital of Uygur Autonomous Region, Urumqi 830013, China
  • Received:2011-06-13 Online:2011-12-30 Published:2011-12-30
  • Contact: Corresponding author Tel: 86-10-65296549, Fax: 86-10-65296351, E-mail: drmaxiaojun@gmail.com E-mail:drmaxiaojun@gmail.com

摘要: PNEUMOCYSTIS pneumonia (PCP) is among the most common opportunistic infections in patients with acquired immune deficiency syndrome (AIDS). Although trimetho-prim-sulfamethoxazole (TMP-SMX) is the first line therapy for that condition given its efficacy, approximately one third of patients experienced dose-limiting toxicity.For cases of severe to moderate PCP, if TMP-SMX treatment fails or is contraindicated, primaquine combined with clindamycin or intravenous pentamidine is recommended as second line therapy. However, both primaquine and pentamidine are associated with severe adverse reactions and often unavailable at hospitals in China.As a result, other treatment options have been explored.
Caspofungin, an echinocandin, has broad antifungal activity against a wide range of fungi including Candida and Aspergillus species. Cases of PCP patients treated with caspofungin have been reported, although conflicting conclusions have been arrived at. In addition, the use of caspofungin and clindamycin as the first line therapy for severe PCP in AIDS patients has not been reported yet. This article described an AIDS case with severe PCP, treated with the combination of caspofungin and clindamycin.

关键词: pneumocystis pneumonia, caspofungin, acquired immune deficiency syndrome, trimethoprim-sulfamethoxazole

Abstract: PNEUMOCYSTIS pneumonia (PCP) is among the most common opportunistic infections in patients with acquired immune deficiency syndrome (AIDS). Although trimetho-prim-sulfamethoxazole (TMP-SMX) is the first line therapy for that condition given its efficacy, approximately one third of patients experienced dose-limiting toxicity.For cases of severe to moderate PCP, if TMP-SMX treatment fails or is contraindicated, primaquine combined with clindamycin or intravenous pentamidine is recommended as second line therapy. However, both primaquine and pentamidine are associated with severe adverse reactions and often unavailable at hospitals in China.As a result, other treatment options have been explored.
Caspofungin, an echinocandin, has broad antifungal activity against a wide range of fungi including Candida and Aspergillus species. Cases of PCP patients treated with caspofungin have been reported, although conflicting conclusions have been arrived at. In addition, the use of caspofungin and clindamycin as the first line therapy for severe PCP in AIDS patients has not been reported yet. This article described an AIDS case with severe PCP, treated with the combination of caspofungin and clindamycin.

Key words: pneumocystis pneumonia, caspofungin, acquired immune deficiency syndrome, trimethoprim-sulfamethoxazole

Copyright © 2018 Chinese Academy of Medical Sciences. All right reserved.
 
www.cmsj.cams.cn
京公安备110402430088 京ICP备06002729号-1  Powered by Magtech.

Supervised by National Health Commission of the People's Republic of China

9 Dongdan Santiao, Dongcheng district, Beijing, 100730 China

Tel: 86-10-65105897  Fax:86-10-65133074 

E-mail: cmsj@cams.cn  www.cmsj.cams.cn

Copyright © 2018 Chinese Academy of Medical Sciences

All right reserved.

京公安备110402430088  京ICP备06002729号-1